Review



phosphorylated nuclear factor kappa b  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech phosphorylated nuclear factor kappa b
    Phosphorylated Nuclear Factor Kappa B, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1017 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated nuclear factor kappa b/product/Proteintech
    Average 96 stars, based on 1017 article reviews
    phosphorylated nuclear factor kappa b - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    96
    Proteintech phosphorylated nuclear factor kappa b
    Phosphorylated Nuclear Factor Kappa B, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated nuclear factor kappa b/product/Proteintech
    Average 96 stars, based on 1 article reviews
    phosphorylated nuclear factor kappa b - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    ZenBio phosphorylated nuclear factor kappa b (p-nf-kb) antibody
    Phosphorylated Nuclear Factor Kappa B (P Nf Kb) Antibody, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated nuclear factor kappa b (p-nf-kb) antibody/product/ZenBio
    Average 90 stars, based on 1 article reviews
    phosphorylated nuclear factor kappa b (p-nf-kb) antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Affinity Biosciences phosphorylated nuclear factor kappa-b p65 (p-nf-κb p65)
    Phosphorylated Nuclear Factor Kappa B P65 (P Nf κb P65), supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated nuclear factor kappa-b p65 (p-nf-κb p65)/product/Affinity Biosciences
    Average 90 stars, based on 1 article reviews
    phosphorylated nuclear factor kappa-b p65 (p-nf-κb p65) - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Affinity Biosciences phosphorylated nuclear factor kappa-b p65
    Phosphorylated Nuclear Factor Kappa B P65, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated nuclear factor kappa-b p65/product/Affinity Biosciences
    Average 90 stars, based on 1 article reviews
    phosphorylated nuclear factor kappa-b p65 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Elabscience Biotechnology phosphorylated nuclear factor kappa b (p-nfφb) assay
    Phosphorylated Nuclear Factor Kappa B (P Nfφb) Assay, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated nuclear factor kappa b (p-nfφb) assay/product/Elabscience Biotechnology
    Average 90 stars, based on 1 article reviews
    phosphorylated nuclear factor kappa b (p-nfφb) assay - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc anti-phosphorylated nuclear factor-kappa b (nf-κb) p65 (p-p65, ser536) antibody
    Rosmarinic acid inhibits nuclear <t>factor-kappa</t> B signaling in colorectal cancer cells. A: Molecular modeling of rosmarinic acid (RA)/inhibitory kappa B kinase beta complex. 3D presentation of the molecular docking complex pose (I), 2D presentation (II), and 3D presentation (III) of the interactions between RA and the key residues of inhibitory kappa B kinase beta; B and C: HT29 (B) and SW480 (C) cells transfected with p-nuclear factor-kappa B-Luc along with Renilla luciferase were incubated with indicated RA overnight, followed by luciferase assay; D: HT29 and SW480 cells were incubated with increasing concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against <t>p-p65</t> and nuclear factor-kappa B P65. GAPDH was used as a loading control; E: Starved HT29 cells were treated with indicated RA for 12 hours, and then cells were incubated with 200 ng/mL lipopolysaccharide for 30 minutes, followed by Western blot analysis using antibodies against p-p65 and GAPDH; F and G: HT29 cells were incubated with increasing concentrations of RA for 24 hours, followed by quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin D1 (F) and MYC (G). GAPDH was used as an internal control. n = 3. Data are shown as the mean ± SD. a P < 0.001 vs group ‘0’, b P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; NF-κB: Nuclear factor-kappa B; LPS: Lipopolysaccharide.
    Anti Phosphorylated Nuclear Factor Kappa B (Nf κb) P65 (P P65, Ser536) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-phosphorylated nuclear factor-kappa b (nf-κb) p65 (p-p65, ser536) antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-phosphorylated nuclear factor-kappa b (nf-κb) p65 (p-p65, ser536) antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc anti-phosphorylated-inhibitor of nuclear factor kappa b alpha p-iκbα
    Rosmarinic acid inhibits nuclear <t>factor-kappa</t> B signaling in colorectal cancer cells. A: Molecular modeling of rosmarinic acid (RA)/inhibitory kappa B kinase beta complex. 3D presentation of the molecular docking complex pose (I), 2D presentation (II), and 3D presentation (III) of the interactions between RA and the key residues of inhibitory kappa B kinase beta; B and C: HT29 (B) and SW480 (C) cells transfected with p-nuclear factor-kappa B-Luc along with Renilla luciferase were incubated with indicated RA overnight, followed by luciferase assay; D: HT29 and SW480 cells were incubated with increasing concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against <t>p-p65</t> and nuclear factor-kappa B P65. GAPDH was used as a loading control; E: Starved HT29 cells were treated with indicated RA for 12 hours, and then cells were incubated with 200 ng/mL lipopolysaccharide for 30 minutes, followed by Western blot analysis using antibodies against p-p65 and GAPDH; F and G: HT29 cells were incubated with increasing concentrations of RA for 24 hours, followed by quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin D1 (F) and MYC (G). GAPDH was used as an internal control. n = 3. Data are shown as the mean ± SD. a P < 0.001 vs group ‘0’, b P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; NF-κB: Nuclear factor-kappa B; LPS: Lipopolysaccharide.
    Anti Phosphorylated Inhibitor Of Nuclear Factor Kappa B Alpha P Iκbα, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-phosphorylated-inhibitor of nuclear factor kappa b alpha p-iκbα/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-phosphorylated-inhibitor of nuclear factor kappa b alpha p-iκbα - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Affinity Biosciences phosphorylated nuclear factor kappa b p65 subunit at ser536 af2006 antibody
    Rosmarinic acid inhibits nuclear <t>factor-kappa</t> B signaling in colorectal cancer cells. A: Molecular modeling of rosmarinic acid (RA)/inhibitory kappa B kinase beta complex. 3D presentation of the molecular docking complex pose (I), 2D presentation (II), and 3D presentation (III) of the interactions between RA and the key residues of inhibitory kappa B kinase beta; B and C: HT29 (B) and SW480 (C) cells transfected with p-nuclear factor-kappa B-Luc along with Renilla luciferase were incubated with indicated RA overnight, followed by luciferase assay; D: HT29 and SW480 cells were incubated with increasing concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against <t>p-p65</t> and nuclear factor-kappa B P65. GAPDH was used as a loading control; E: Starved HT29 cells were treated with indicated RA for 12 hours, and then cells were incubated with 200 ng/mL lipopolysaccharide for 30 minutes, followed by Western blot analysis using antibodies against p-p65 and GAPDH; F and G: HT29 cells were incubated with increasing concentrations of RA for 24 hours, followed by quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin D1 (F) and MYC (G). GAPDH was used as an internal control. n = 3. Data are shown as the mean ± SD. a P < 0.001 vs group ‘0’, b P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; NF-κB: Nuclear factor-kappa B; LPS: Lipopolysaccharide.
    Phosphorylated Nuclear Factor Kappa B P65 Subunit At Ser536 Af2006 Antibody, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated nuclear factor kappa b p65 subunit at ser536 af2006 antibody/product/Affinity Biosciences
    Average 90 stars, based on 1 article reviews
    phosphorylated nuclear factor kappa b p65 subunit at ser536 af2006 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc phosphorylated nuclear factor kappa b p65
    Rosmarinic acid inhibits nuclear <t>factor-kappa</t> B signaling in colorectal cancer cells. A: Molecular modeling of rosmarinic acid (RA)/inhibitory kappa B kinase beta complex. 3D presentation of the molecular docking complex pose (I), 2D presentation (II), and 3D presentation (III) of the interactions between RA and the key residues of inhibitory kappa B kinase beta; B and C: HT29 (B) and SW480 (C) cells transfected with p-nuclear factor-kappa B-Luc along with Renilla luciferase were incubated with indicated RA overnight, followed by luciferase assay; D: HT29 and SW480 cells were incubated with increasing concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against <t>p-p65</t> and nuclear factor-kappa B P65. GAPDH was used as a loading control; E: Starved HT29 cells were treated with indicated RA for 12 hours, and then cells were incubated with 200 ng/mL lipopolysaccharide for 30 minutes, followed by Western blot analysis using antibodies against p-p65 and GAPDH; F and G: HT29 cells were incubated with increasing concentrations of RA for 24 hours, followed by quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin D1 (F) and MYC (G). GAPDH was used as an internal control. n = 3. Data are shown as the mean ± SD. a P < 0.001 vs group ‘0’, b P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; NF-κB: Nuclear factor-kappa B; LPS: Lipopolysaccharide.
    Phosphorylated Nuclear Factor Kappa B P65, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phosphorylated nuclear factor kappa b p65/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    phosphorylated nuclear factor kappa b p65 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    Rosmarinic acid inhibits nuclear factor-kappa B signaling in colorectal cancer cells. A: Molecular modeling of rosmarinic acid (RA)/inhibitory kappa B kinase beta complex. 3D presentation of the molecular docking complex pose (I), 2D presentation (II), and 3D presentation (III) of the interactions between RA and the key residues of inhibitory kappa B kinase beta; B and C: HT29 (B) and SW480 (C) cells transfected with p-nuclear factor-kappa B-Luc along with Renilla luciferase were incubated with indicated RA overnight, followed by luciferase assay; D: HT29 and SW480 cells were incubated with increasing concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against p-p65 and nuclear factor-kappa B P65. GAPDH was used as a loading control; E: Starved HT29 cells were treated with indicated RA for 12 hours, and then cells were incubated with 200 ng/mL lipopolysaccharide for 30 minutes, followed by Western blot analysis using antibodies against p-p65 and GAPDH; F and G: HT29 cells were incubated with increasing concentrations of RA for 24 hours, followed by quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin D1 (F) and MYC (G). GAPDH was used as an internal control. n = 3. Data are shown as the mean ± SD. a P < 0.001 vs group ‘0’, b P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; NF-κB: Nuclear factor-kappa B; LPS: Lipopolysaccharide.

    Journal: World Journal of Clinical Oncology

    Article Title: Natural compound rosmarinic acid displays anti-tumor activity in colorectal cancer cells by suppressing nuclear factor-kappa B signaling

    doi: 10.5306/wjco.v16.i5.105341

    Figure Lengend Snippet: Rosmarinic acid inhibits nuclear factor-kappa B signaling in colorectal cancer cells. A: Molecular modeling of rosmarinic acid (RA)/inhibitory kappa B kinase beta complex. 3D presentation of the molecular docking complex pose (I), 2D presentation (II), and 3D presentation (III) of the interactions between RA and the key residues of inhibitory kappa B kinase beta; B and C: HT29 (B) and SW480 (C) cells transfected with p-nuclear factor-kappa B-Luc along with Renilla luciferase were incubated with indicated RA overnight, followed by luciferase assay; D: HT29 and SW480 cells were incubated with increasing concentrations of RA for 24 hours, followed by Western blot analysis using antibodies against p-p65 and nuclear factor-kappa B P65. GAPDH was used as a loading control; E: Starved HT29 cells were treated with indicated RA for 12 hours, and then cells were incubated with 200 ng/mL lipopolysaccharide for 30 minutes, followed by Western blot analysis using antibodies against p-p65 and GAPDH; F and G: HT29 cells were incubated with increasing concentrations of RA for 24 hours, followed by quantitative real-time polymerase chain reaction to evaluate the mRNA levels of cyclin D1 (F) and MYC (G). GAPDH was used as an internal control. n = 3. Data are shown as the mean ± SD. a P < 0.001 vs group ‘0’, b P < 0.0001 vs group ‘0’. RA: Rosmarinic acid; NF-κB: Nuclear factor-kappa B; LPS: Lipopolysaccharide.

    Article Snippet: Anti-phosphorylated nuclear factor-kappa B (NF-κB) P65 (p-p65, Ser536) antibody, anti-NF-κB P65 antibody, anti-Bcl-2 antibody, anti-caspase-3 antibody, and anti-phosphorylated protein kinase B (p-AKT, Ser473) antibody were purchased from Cell Signaling Technology, Danvers, MA, United States.

    Techniques: Transfection, Luciferase, Incubation, Western Blot, Control, Real-time Polymerase Chain Reaction